View : 624 Download: 0

Full metadata record

DC Field Value Language
dc.contributor.author김현수-
dc.date.accessioned2017-01-05T02:01:48Z-
dc.date.available2017-01-05T02:01:48Z-
dc.date.issued2010-
dc.identifier.issn0014-2999-
dc.identifier.otherOAK-6306-
dc.identifier.urihttps://dspace.ewha.ac.kr/handle/2015.oak/233455-
dc.description.abstractDiabetes mellitus has been known to mitigate ischemic or pharmacologic preconditioning in ischemia-reperfusion injuries. Remifentanil is a widely used opioid in cardiac anesthesia that possesses a cardioprotective effect against ischemia-reperfusion. We evaluated whether diabetes affected remifentanil preconditioning induced cardioprotection in ischemia-reperfusion rat hearts in view of anti-apoptotic pathways of survival and Ca2+ homeostasis. Streptozotocin-induced, diabetic rats and age-matched wild-type Sprague-Dawley rats were subjected to a left anterior descending coronary artery occlusion for 30 min followed by 1 h of reperfusion. Each diabetic and wild-type rat was randomly assigned to the sham, ischemia-reperfusion only, or remifentanil preconditioning group. Myocardial infarct size, activities of ERK1/2, Bcl2, Bax and cytochrome c, and gene expression influencing Ca2+ homeostasis were assessed. Remifentanil preconditioning significantly reduced myocardial infarct size compared to ischemia-reperfusion only in wild-type rats but not in diabetic rats. Remifentanil preconditioning increased expression of ERK1/2 and anti-apoptotic protein Bcl-2 and decreased expression of pro-apoptotic proteins, Bax and cytochrome c, compared to ischemia-reperfusion only in wild-type rats. In diabetic rat hearts, however, remifentanil preconditioning failed to recover the phosphorylation state of ERK1/2 and to repress apoptotic signaling. In addition, diabetes minimized remifentanil induced modulation of abnormal changes in sarcoplasmic reticulum genes and proteins in ischemia-reperfusion rat hearts. In conclusion, diabetes mitigated remifentanil induced cardioprotection against ischemia-reperfusion, which might be associated with reduced recovery of the activities of proteins involved in anti-apoptotic pathways including ERK1/2 and the abnormal expression of sarcoplasmic reticulum genes as a result of ischemia-reperfusion in rat hearts. © 2009 Elsevier B.V. All rights reserved.-
dc.languageEnglish-
dc.titleDiabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival-
dc.typeArticle-
dc.relation.issue41277-
dc.relation.volume628-
dc.relation.indexSCI-
dc.relation.indexSCIE-
dc.relation.indexSCOPUS-
dc.relation.startpage132-
dc.relation.lastpage139-
dc.relation.journaltitleEuropean Journal of Pharmacology-
dc.identifier.doi10.1016/j.ejphar.2009.11.032-
dc.identifier.wosidWOS:000274784500019-
dc.identifier.scopusid2-s2.0-73649115943-
dc.author.googleKim H.S.-
dc.author.googleCho J.E.-
dc.author.googleHwang K.C.-
dc.author.googleShim Y.H.-
dc.author.googleLee J.H.-
dc.author.googleKwak Y.L.-
dc.contributor.scopusid김현수(57191717719;57191718092)-
dc.date.modifydate20230620101535-
Appears in Collections:
자연과학대학 > 생명과학전공 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

BROWSE